The Effects of Cigarette Addiction on Lower Extremity Movement Speed and Coordination
The Effects of Cigarette Addiction on Lower Extremity Movement Speed and Coordination in Young Adults
Saglik Bilimleri Universitesi
24 participants
Jul 29, 2025
OBSERVATIONAL
Conditions
Summary
This observational study will aim to investigate the effects of cigarette addiction on lower extremity motor coordination and movement speed in young adults. The study will include healthy participants aged 18-25 years, divided into smokers and non-smokers. Motor coordination will be assessed using the Lower Extremity Motor Coordination Test (LEMOCOT), and speed will be evaluated with a 30-meter sprint test. Nicotine dependence will be evaluated in smokers using the Fagerström Test. The findings will provide insight into the possible functional impacts of nicotine addiction on motor performance.
Eligibility
Inclusion Criteria7
- Age between 18 and 25 years
- Able to walk independently
- Literate and cooperative
- Willing to participate voluntarily
- BMI between 18.5 and 29.9 kg/m²
- Additional inclusion for smokers:
- Daily smoking for at least one year based on WHO and DSM-IV-TR definitions
Exclusion Criteria7
- Orthopedic, neurologic, or neuromuscular disorders affecting gait
- Chronic cardiopulmonary disease
- Cognitive impairments
- Obesity (BMI ≥ 30 kg/m²)
- Additional exclusion for smokers:
- History of acute cardiovascular events
- Chronic heart failure or lung diseases
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This study will include only observational functional assessments. No active intervention will be performed.This observational protocol will involve standardized assessments of lower extremity coordination (LEMOCOT), movement speed (30-meter sprint), and smoking-related behavioral patterns (Fagerström Test for Nicotine Dependence). These tools will be used to evaluate the potential impact of cigarette addiction on physical performance in young adults. No therapeutic or pharmacological intervention will be applied.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07075068